Prognosis of Hepatitis C


The prognosis of Hepatitis C varies from case to case. Some individuals may never experience any complications due to the disease, while some with chronic hepatitis C may develop cirrhosis. Those who develop cirrhosis may suffer from liver failure. In such cases, a liver transplant may be the only treatment available. In other cases, the cirrhosis and inflammation of the liver due to chronic infection may contribute to liver cancer. In a small number of cases, people with hepatitis C may experience complications outside of the liver. The disease may affect the joints, muscles, skin, kidneys, connective tissues, blood or bone marrow. 
References
  1. Alajos Pár, László Telegdy, Lajos Dalmi, Eva Müller, Hungarian Viral Hepatitis Treatment Study Group, Therapy for chronic hepatitis C, Journal of Physiology-Paris, Volume 95, Issues 1–6, January–December 2001, Pages 399-405, ISSN 0928-4257, 10.1016/S0928-4257(01)00054-7.
  2. Jacqueline Rhoads, Natural History and Epidemiology of Hepatitis C, Journal of the Association of Nurses in AIDS care, Volume 14, Issue 5, Supplement, September–October 2003, Pages 18S-25S, ISSN 1055-3290, 10.1177/1055329003254854.
  3. Samer S. El-Kamary, Michelle D. Shardell, Mohamed Abdel-Hamid, Soheir Ismail, Mohamed El-Ateek, Mohamed Metwally, Nabiel Mikhail, Mohamed Hashem, Amr Mousa, Amr Aboul-Fotouh, Mohamed El-Kassas, Gamal Esmat, G. Thomas Strickland, A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis, Phytomedicine, Volume 16, Issue 5, May 2009, Pages 391-400, ISSN 0944-7113, 10.1016/j.phymed.2009.02.002.